NOVARTIS OPHTHALMICS RECALLS SEVEN LOTS OF GENTEAL PRODUCTS IN THE US
Novartis Ophthalmics announced today it has voluntarily recalled a total of seven lots of two products intended for use in the eye. Novartis Ophthalmics takes its mission of patient care and providing quality products very seriously, and therefore, believes it is necessary to take this precautionary action. The recalls are being conducted with the knowledge of the FDA. Novartis Ophthalmics is recalling five lots of GenTeal(R) Gel, a non-prescription drug product used to relieve dryness of the eye.